NMTC
NMTC
NASDAQ · Health Care

Neuroone Medical Technologie

$3.04
-0.30 (-8.98%)
As of Jun 30, 10:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
15.14M
Net Income
-4,512,836
Gross Margin
67.3%
Profit Margin
-29.8%
Rev Growth
+78.7%
D/E Ratio
0.18
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.3% 67.3% 33.8% 33.8%
Operating Margin -34.9% -31.4% 18.5% 22.7%
Profit Margin -29.8% -28.3% 17.8% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 15.14M 8.47M 9.42M 7.53M
Gross Profit 10.19M 5.70M 3.18M 2.55M
Operating Income -5,291,171 -2,664,831 1.75M 1.71M
Net Income -4,512,836 -2,272,832 1.68M 1.31M
Gross Margin 67.3% 67.3% 33.8% 33.8%
Operating Margin -34.9% -31.4% 18.5% 22.7%
Profit Margin -29.8% -28.3% 17.8% 17.4%
Rev Growth +78.7% +78.7% +23.2% +0.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.13M 2.13M 19.89M 16.57M
Total Equity 11.87M 11.87M 26.14M 26.84M
D/E Ratio 0.18 0.18 0.76 0.62
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,962,695 -2,638,254 2.43M 1.90M
Free Cash Flow 1.05M 840.7K